INHIBITORS OF GST A3-3 AND GST A1-1 FOR THE TREATMENT OF CANCER

Details for Australian Patent Application No. 2003279691 (hide)

Owner MANNERVIK, Bengt

Inventors Mannervik, Bengt

Agent Davies Collison Cave

Pub. Number AU-A-2003279691

PCT Number PCT/SE03/01817

PCT Pub. Number WO2004/048577

Priority 0203479-1 22.11.02 SE

Filing date 24 November 2003

Wipo publication date 18 June 2004

International Classifications

C12N 015/54 Mutation or genetic engineering - Transferases (2)

C12Q 001/48 Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12N 009/10 Enzymes, e.g. ligases (6.) - Transferases (2.)

C07K 014/47 Peptides having more than 20 amino acids

C07D 209/14 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 0203479-1 22.11.02 SE

22 July 2004 Application Open to Public Inspection

  Published as AU-A-2003279691

7 June 2007 Assignment before Grant

  Biovitrum AB The application has been assigned to Mannervik, Bengt 2004

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003279692-PACKAGING DEVICE

2003279690-SYNTHESIS OF PURINE DERIVATIVES